Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models-Reference-Cited by-同舟云学术

Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models

Published:2017-07-05 Issue:7 Volume:14 Page:e1002310
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Dyson Alex^ORCID,Dal-Pizzol Felipe,Sabbatini Giovanni,Lach Anna B.,Galfo Federica^ORCID,dos Santos Cardoso Juliano,Pescador Mendonça Bruna,Hargreaves Iain,Bollen Pinto Bernardo,Bromage Daniel I.,Martin John F.,Moore Kevin P.,Feelisch Martin,Singer Mervyn^ORCID

Funder

Magnus Oxygen Ltd

Newton Fund

FAPESC (Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina)

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference56 articles.

1. Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning;T Kalogeris;Redox Biol,2014

2. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet,2016

3. Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke;CJ Smith;Expert Opin Investig Drugs,2015